According to AlphaMoat, in October 2026 Iambic Therapeutics (iambic.ai) received 24,995 monthly visits (-5.4% MoM) — ranked #6,829 of 17,609 AI websites with traffic data, and #877 of 3,112 in Industry Services; its largest market is United States (96.0% of visits).
Iambic Therapeutics (formerly Entos) uses artificial intelligence to predict protein and ligand structures and generate molecular designs to discover new drugs.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 17.6K | — |
| 2026-07 | 10.2K | -41.7% |
| 2026-08 | 16.9K | +64.8% |
| 2026-09 | 26.4K | +56.5% |
| 2026-10 | 25.0K | -5.4% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, Iambic Therapeutics (iambic.ai) received 24,995 visits (about 25.0K) in October 2026 (-5.4% month over month), ranking #6,829 of 17,609 AI websites with traffic data, and #877 in Industry Services.
In October 2026, Iambic Therapeutics’s largest markets by share of visits are United States 96.0%, Canada 3.9%, India 0.1%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.